These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 8494898)
1. Role of native disulfide bonds in the structure and activity of insulin-like growth factor 1: genetic models of protein-folding intermediates. Narhi LO; Hua QX; Arakawa T; Fox GM; Tsai L; Rosenfeld R; Holst P; Miller JA; Weiss MA Biochemistry; 1993 May; 32(19):5214-21. PubMed ID: 8494898 [TBL] [Abstract][Full Text] [Related]
2. Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro. Hober S; Uhlén M; Nilsson B Biochemistry; 1997 Apr; 36(15):4616-22. PubMed ID: 9109671 [TBL] [Abstract][Full Text] [Related]
3. Oxidative refolding of insulin-like growth factor 1 yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway. Miller JA; Narhi LO; Hua QX; Rosenfeld R; Arakawa T; Rohde M; Prestrelski S; Lauren S; Stoney KS; Tsai L Biochemistry; 1993 May; 32(19):5203-13. PubMed ID: 8494897 [TBL] [Abstract][Full Text] [Related]
4. The different energetic state of the intra A-chain/domain disulfide of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain. Guo ZY; Shen L; Feng YM Biochemistry; 2002 Aug; 41(34):10585-92. PubMed ID: 12186542 [TBL] [Abstract][Full Text] [Related]
5. The folding nucleus of the insulin superfamily: a flexible peptide model foreshadows the native state. Hua QX; Mayer JP; Jia W; Zhang J; Weiss MA J Biol Chem; 2006 Sep; 281(38):28131-42. PubMed ID: 16864583 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties. Milner SJ; Francis GL; Wallace JC; Magee BA; Ballard FJ Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):865-71. PubMed ID: 8948444 [TBL] [Abstract][Full Text] [Related]
7. Probing the disulfide folding pathway of insulin-like growth factor-I. Milner SJ; Carver JA; Ballard FJ; Francis GL Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525 [TBL] [Abstract][Full Text] [Related]
8. A protein caught in a kinetic trap: structures and stabilities of insulin disulfide isomers. Hua QX; Jia W; Frank BH; Phillips NF; Weiss MA Biochemistry; 2002 Dec; 41(50):14700-15. PubMed ID: 12475219 [TBL] [Abstract][Full Text] [Related]
9. Hierarchical protein folding: asymmetric unfolding of an insulin analogue lacking the A7-B7 interchain disulfide bridge. Hua QX; Nakagawa SH; Jia W; Hu SQ; Chu YC; Katsoyannis PG; Weiss MA Biochemistry; 2001 Oct; 40(41):12299-311. PubMed ID: 11591149 [TBL] [Abstract][Full Text] [Related]
10. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain. Guo ZY; Shen L; Feng YM Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349 [TBL] [Abstract][Full Text] [Related]
11. Disulfide exchange folding of insulin-like growth factor I. Hober S; Forsberg G; Palm G; Hartmanis M; Nilsson B Biochemistry; 1992 Feb; 31(6):1749-56. PubMed ID: 1737028 [TBL] [Abstract][Full Text] [Related]
12. Native and non-native structure in a protein-folding intermediate: spectroscopic studies of partially reduced IGF-I and an engineered alanine model. Hua QX; Narhi L; Jia W; Arakawa T; Rosenfeld R; Hawkins N; Miller JA; Weiss MA J Mol Biol; 1996 Jun; 259(2):297-313. PubMed ID: 8656430 [TBL] [Abstract][Full Text] [Related]
13. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1. Wang S; Guo ZY; Shen L; Zhang YJ; Feng YM Biochemistry; 2003 Aug; 42(32):9687-93. PubMed ID: 12911310 [TBL] [Abstract][Full Text] [Related]
14. Local structural preferences in the alpha-lactalbumin molten globule. Peng ZY; Wu LC; Kim PS Biochemistry; 1995 Mar; 34(10):3248-52. PubMed ID: 7880819 [TBL] [Abstract][Full Text] [Related]
15. Putative disulfide-forming pathway of porcine insulin precursor during its refolding in vitro. Qiao ZS; Guo ZY; Feng YM Biochemistry; 2001 Mar; 40(9):2662-8. PubMed ID: 11258877 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors I and II are unable to form and maintain their native disulfides under in vivo redox conditions. Hober S; Lundström Ljung J; Uhlén M; Nilsson B FEBS Lett; 1999 Jan; 443(3):271-6. PubMed ID: 10025946 [TBL] [Abstract][Full Text] [Related]
17. Mutation of Arg55/56 to Leu55/Ala56 in insulin-like growth factor-I results in two forms different in disulfide structure and native conformation but similar under reverse-phase conditions. Rosenfeld RD; Noone NM; Lauren SL; Rohde MF; Narhi LO; Arakawa T J Protein Chem; 1993 Jun; 12(3):247-54. PubMed ID: 8397784 [TBL] [Abstract][Full Text] [Related]
18. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor. Liu Y; Breslauer K; Anderson S Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914 [TBL] [Abstract][Full Text] [Related]
19. Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein. Hober S; Hansson A; Uhlén M; Nilsson B Biochemistry; 1994 Jun; 33(22):6758-61. PubMed ID: 7515683 [TBL] [Abstract][Full Text] [Related]
20. Three-dimensional solution structure of a disulfide bond isomer of the human insulin-like growth factor-I. Sato A; Koyama S; Yamada H; Suzuki S; Tamura K; Kobayashi M; Niwa M; Yasuda T; Kyogoku Y; Kobayashi Y J Pept Res; 2000 Oct; 56(4):218-30. PubMed ID: 11083061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]